Regulatory Story
Go to market news section View chart   Print
RNS
Dechra Pharmaceuticals PLC  -  DPH   

Holding(s) in Company

Released 11:45 02-Jan-2013

RNS Number : 6493U
Dechra Pharmaceuticals PLC
02 January 2013
 



 

 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

  Dechra Pharmaceuticals plc

 

2 Reason for the notification (please tick the appropriate box or boxes):

 

An acquisition or disposal of voting rights


X

 

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached


 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments


 

An event changing the breakdown of voting rights


 

Other (please specify):

 


 

3. Full name of person(s) subject to the notification obligation:

 


Invesco Limited

4. Full name of shareholder(s) (if different from 3.):

 


5. Date of the transaction and date on which the threshold is crossed or reached:

 


20 December 2012

6. Date on which issuer notified:

 


21 December 2012

7. Threshold(s) that is/are crossed or reached:

 


5%

 

8. Notified details:

A: Voting rights attached to shares

 

Class/type of
shares


if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of  voting rights

Direct

Direct

Indirect

Direct

Indirect


Ordinary 1p Shares


4,298,246


4,298,246




4,348,519



5.00%


GB0009633180

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financial
instrument

Expiration
date

Exercise/
Conversion
Period

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

 

% of voting
rights






 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financial
instrument

Exercise
price

Expiration
date

Exercise/
Conversion
period

Number of voting
rights instrument
refers to

% of voting rights

 






Nominal

Delta

 



 

Total (A+B+C)

 

Number of voting rights

Percentage of voting rights

4,348,519

5.00%

 

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:

 

Invesco Asset Management Ltd - 936,587

Invesco Fund Managers Ltd - 3,068,384

Incesco Asset Management Dublin Ltd - 274,501

Invesco Asset Management Ltd & Invesco Advisers Inc. - 23,461

Invesco Canada Ltd & Invesco Advisers Inc. - 21,954

Invesco GT Management S.A - 12,877

Invesco Asset Management Japan Ltd - 6,145

Invesco PowerShares Capital  Management Limited - 4,610

 

 

Proxy Voting:

 

10. Name of the proxy holder:

 


11. Number of voting rights proxy holder will cease to hold:

 


12. Date on which proxy holder will cease to hold voting rights:

 


 

13. Additional information:

 


14. Contact name:

 


Samantha Edwards

15. Contact telephone number:

 


01491 416381

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLMMGGMMZGGFZM
Close


London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.

 


Holding(s) in Company - RNS